TAK-007
TAK-007-1001
Phase 1 mab terminated
Quick answer
TAK-007 for Refractory Lupus Nephritis is a Phase 1 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Refractory Lupus Nephritis
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated